Falcon Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.30 Cr
as on 05-07-2024
- Satisfied Charges ₹ 2.30 Cr
as on 05-07-2024
- Revenue -73.88%
(FY 2023)
- Profit -57.77%
(FY 2023)
- Ebitda -55.78%
(FY 2023)
- Net Worth 18.32%
(FY 2023)
- Total Assets -20.52%
(FY 2023)
About Falcon Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.30 Cr. The company has closed loans amounting to ₹2.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Jindal, Ishaan Jindal, Rekha Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232CH2007PTC030754
- Company No.
030754
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Social Media
What products or services does Falcon Biotech Private Limited offer?
Falcon Biotech Private Limited offers a wide range of products and services, including Medical Pumps, Syringe Pump, Patient Monitoring System, Cardiac & Multi Parameter Patient Monitor, Ultrasound Machines, GE Ultrasound Machine, Used Machinery & Tools, Refurbished Medical Equipment.
Who are the key members and board of directors at Falcon Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishaan Jindal  | Director | 27-Sep-2018 | Current |
| Ajay Jindal | Director | 27-Mar-2007 | Current |
| Rekha Sharma | Director | 27-Sep-2018 | Current |
| Anju Jindal | Additional Director | 21-Nov-2009 | Current |
Financial Performance of Falcon Biotech.
Falcon Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 73.88% decrease. The company also saw a substantial fall in profitability, with a 57.77% decrease in profit. The company's net worth Soared by an impressive increase of 18.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Falcon Biotech?
In 2023, Falcon Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 25 Oct 2023 | ₹4.80 Cr | Open |
City Union Bank Limited Creation Date: 26 Aug 2022 | ₹2.50 Cr | Open |
Axis Bank Limited Creation Date: 10 Oct 2018 | ₹1.50 M | Satisfied |
How Many Employees Work at Falcon Biotech?
Unlock and access historical data on people associated with Falcon Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Falcon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Falcon Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
